<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.09419.006</object-id><label>Table 1.</label><caption><p>Baseline demographic characteristics of the 201 patients who underwent CXCL13 analyses.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.09419.006">http://dx.doi.org/10.7554/eLife.09419.006</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Characteristics</th><th colspan="3">Total</th><th colspan="3">Highly polluted region (HPR)</th><th colspan="3">Control region (CR)</th><th rowspan="2">p values <break/>(HPR vs CR)</th></tr><tr><th>Case, n</th><th>CXCL13 high, <break/>n (%)</th><th>p values</th><th>Case, n</th><th>CXCL13 high, <break/>n (%)</th><th>p values</th><th>Case, n</th><th>CXCL13 high, <break/>n (%)</th><th>p values</th></tr></thead><tbody><tr><td>Total</td><td>201</td><td>134 (66.7)</td><td/><td>70</td><td>63 (90)</td><td/><td>131</td><td>71 (54.2)</td><td/><td>0.0000003</td></tr><tr><td>G: Male</td><td>134</td><td>88 (65.7)</td><td>0.67</td><td>47</td><td>41 (87.2)</td><td>0.27</td><td>87</td><td>47 (54)</td><td>0.95</td><td>0.0001</td></tr><tr><td>&#160;Female</td><td>67</td><td>46 (68.7)</td><td/><td>23</td><td>22 (95.7)</td><td/><td>44</td><td>24 (54.5)</td><td/><td>0.0006</td></tr><tr><td>A: &lt;65 y</td><td>140</td><td>98 (70)</td><td>0.21</td><td>56</td><td>51 (91.1)</td><td>0.55</td><td>84</td><td>47 (56)</td><td>0.7</td><td>0.000009</td></tr><tr><td>&#160;&#8805;65 y</td><td>56</td><td>34 (60.7)</td><td/><td>14</td><td>12 (85.7)</td><td/><td>42</td><td>22 (52.4)</td><td/><td>0.03</td></tr><tr><td>Unknown</td><td>5</td><td>2 (40)</td><td/><td/><td/><td/><td>5</td><td>2 (40)</td><td/><td/></tr><tr><td>S: Smoker</td><td>107</td><td>75 (70.1)</td><td>0.18</td><td>36</td><td>31 (86.1)</td><td>0.17</td><td>71</td><td>44 (62)</td><td>0.04</td><td>0.01</td></tr><tr><td>&#160;Non-smoker</td><td>87</td><td>53 (60.9)</td><td/><td>27</td><td>26 (96.3)</td><td/><td>60</td><td>27 (45)</td><td/><td>0.000006</td></tr><tr><td>&#160;Unknown</td><td>7</td><td>6 (85.7)</td><td/><td>7</td><td>6 (85.7)</td><td/><td/><td/><td/><td/></tr><tr><td>H: Adenocarcinoma (AD)</td><td>131</td><td>91 (69.5)</td><td>0.45</td><td>48</td><td>44 (91.7)</td><td>0.37</td><td>83</td><td>47 (56.6)</td><td>0.84</td><td>0.00003</td></tr><tr><td>Squamous cell carcinoma&#160;(SCC)</td><td>61</td><td>39 (63.9)</td><td/><td>19</td><td>16 (84.2)</td><td/><td>42</td><td>23 (54.8)</td><td/><td>0.03</td></tr><tr><td>Others</td><td>9</td><td>4 (44.4)</td><td/><td>3</td><td>3 (100)</td><td/><td>6</td><td>1 (16.7)</td><td/><td/></tr><tr><td>Tumor node metastasis&#160;(TNM): I</td><td>88</td><td>51 (58)</td><td>0.007</td><td>29</td><td>23 (79.3)</td><td>0.02</td><td>59</td><td>28 (47.5)</td><td>0.05</td><td>0.004</td></tr><tr><td>&#160;II</td><td>27</td><td>17 (63)</td><td/><td>9</td><td>8 (88.9)</td><td/><td>18</td><td>9 (50)</td><td/><td>0.005</td></tr><tr><td>&#160;III</td><td>58</td><td>43 (74.1)</td><td/><td>17</td><td>17 (100)</td><td/><td>41</td><td>26 (63.4)</td><td/><td>0.004</td></tr><tr><td>&#160;IV</td><td>22</td><td>19 (86.4)</td><td/><td>11</td><td>11 (100)</td><td/><td>11</td><td>8 (72.7)</td><td/><td>0.06</td></tr><tr><td>&#160;Unknown</td><td>6</td><td>4 (66.7)</td><td/><td>4</td><td>4 (100)</td><td/><td>2</td><td>0 (0)</td><td/><td/></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><p>G, gender; A, age; S, smoke; H, histology.</p></fn></table-wrap-foot></table-wrap>